Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00306462 · ClinicalTrials.gov registry record · NA
Trial of Magnesium Sulfate Tocolysis Versus Nifedipine Tocolysis in Women With Preterm Labor
A NA study, sponsored by University of Cincinnati.
- Terminated
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT00306462 is a NA study that was terminated before completion, run by University of Cincinnati. The registered enrollment target is 33 participants.
The verdict
NCT00306462, a NA study, was terminated before completion, sponsored by University of Cincinnati.
- TERMINATED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
Primary Hypothesis: Acute tocolysis (48 hours) using oral nifedipine is more effective than intravenous magnesium sulfate in prolonging pregnancy in women with preterm labor with intact membranes between 24 and 32 6/7 weeks' gestation.
Interventions
- DRUG Magnesium sulfate
- DRUG Oral Nifedipine or placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2006-03 |
| Est. Completion | 2009-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00306462
The ClinicalTrials.gov registry entry for NCT00306462 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Magnesium sulfate is the first listed.
NCT00306462 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00306462 about?
NCT00306462 is a clinical study titled "Trial of Magnesium Sulfate Tocolysis Versus Nifedipine Tocolysis in Women With Preterm Labor". Primary Hypothesis: Acute tocolysis (48 hours) using oral nifedipine is more effective than intravenous magnesium sulfate in prolonging pregnancy in women with preterm labor with intact membranes between 24 and 32 6/7 weeks' gestation.
What is the current status of trial NCT00306462?
This trial is currently terminated. It is a NA study. The enrollment target is 33 participants. The study started on 2006-03. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00306462?
The interventions under investigation include: Magnesium sulfate (DRUG), Oral Nifedipine or placebo (DRUG).
Who is sponsoring clinical trial NCT00306462?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.